Home > Products > CD19 & CD47
> Recombinant Anti-CD19 x Anti-CD47 Bispecific Antibody (Fv-IgG)
Recombinant Anti-CD19 x Anti-CD47 Bispecific Antibody (Fv-IgG) (CAT#: BSDG-042)
Recombinant Anti-CD19 x Anti-CD47 Bispecific Antibody (Fv-IgG) is an appended IgG format, which has 2+2 antigen-binding valency. This dual variable domain IgG is generated by appending variable domains of an anti-CD19 IgG with similar domains from an anti-CD47 antibody via short peptide linkers, or vice versa. This BsAb can retarget macrophages to tumor cells. It is designed for the research of B cell lymphoma; Follicular lymphoma; Burkitt lymphoma; Leukemia therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD19 x Anti-CD47 Bispecific Antibody (Fv-IgG) (BSDG-042). Click the button below to contact us or submit your feedback about this product.